The domestic industrial robotics leader, Estun Automation Co.,Ltd. (02715), released its H1 2026 earnings forecast on July 14th. It anticipates net profit attributable to shareholders will reach between 150 million and 180 million yuan, representing a staggering year-on-year increase of 2,144.74% to 2,593.68%. After excluding non-recurring gains and losses, the net profit is projected to be 60-75 million yuan, successfully turning a profit compared to a loss in the same period last year.
Initial Market Reaction
This dramatic 21-fold financial surge naturally triggered a strong reaction in the secondary market. The following day, Estun's stock price opened over 5% higher, then surged more than 9% before rapidly retreating in the afternoon session. By the close, the share price was up 2.93% at HK$21.1.
Analyzing the Profit Surge
Beyond capturing intense market attention, the explosive earnings growth has also sparked debate. Is Estun's profit surge merely a one-time spike from asset disposals, or is it a genuine signal of a business cycle reversal and a reconstructed profit model?
Estun is a leading domestic intelligent manufacturing enterprise, with two core segments: automation core components & motion control systems, and industrial robots & intelligent manufacturing systems. The company provides a full-chain product portfolio including servos, inverters, and machine vision. It offers 96 robot models with payloads from 3kg to 1200kg and over 20 industry-leading intelligent workstation solutions for processes like bending and welding. It has a deep presence in the new energy sector and empowers smart factories through its AI digital platform.
According to MIR data, Estun's shipment volume ranked first in China's industrial robot market in 2025 (including all domestic and foreign brands), leading in application areas such as sheet metal bending and stamping.
The substantial increase in H1 net profit is primarily composed of two parts. The first is a significant non-recurring gain from the asset restructuring of a participating company, Nanjing Process, where Estun's equity stake was swapped for listed shares of Nanjing Chemical Fibre. This resulted in a substantial fair value gain, constituting a one-time, non-sustainable asset profit that only provides short-term earnings momentum.
The second, and most valuable, component is the improvement in core operations. The company's announcement highlighted three key internal improvement paths: proactively optimizing the product mix by scaling back low-margin orders and focusing resources on high-value-added products and quality customer orders; implementing comprehensive cost reduction and efficiency enhancement measures across the supply chain, R&D design iteration, and lean manufacturing to boost gross margins; and strengthening internal refined management, strictly controlling budgets and expenses, leading to a year-on-year decline in the period expense ratio, further amplifying profit elasticity.
Sustained Operational Turnaround
Typically, a return to profitability on a non-GAAP basis is the most robust signal of an operational inflection point. A review of consecutive financial reports reveals that Estun's operational quality recovery is not a short-term fluke. Over a longer period, the earnings recovery indicated in this half-year forecast is a continuation of the execution of its business strategy since 2025.
For the full year 2025, the company achieved revenue of 4.888 billion yuan, up 21.93% year-on-year, with net profit attributable to shareholders doubling to 45 million yuan. Most notably, operating cash flow reached 507 million yuan, a massive 788.37% year-on-year increase, indicating that cash flow was the first to complete a bottoming and reversal.
The company's ongoing optimization of expense control is also significant. The period expense ratio for 2025 was 29.29%, down 9.44 percentage points year-on-year. The sales, administrative, financial, and R&D expense ratios were 9.19%, 8.39%, 3.14%, and 8.57% respectively, all showing notable declines. While continuing to increase investment in international market expansion, the company further reduced its period expense ratio through refined management and budget control.
Entering Q1 2026, Estun shifted its strategic focus entirely from scale expansion to profit prioritization. Against a backdrop of a slight 2.22% dip in revenue, net profit attributable to shareholders surged 674.64%, fully demonstrating the effectiveness of gross margin improvement and expense control.
From the initial cash flow recovery and full-year profit repair, to the quarterly profit explosion and half-year non-GAAP return to profitability, a clear and complete path of operational turnaround is visible.
Market Context and Valuation
There is no doubt that the industrial robotics market where Estun operates is a high-beta growth sector. According to Wanlian Securities, the humanoid robotics industry has clear long-term drivers and vast market potential. Global aging trends are intensifying, leading to a tightening labor supply-demand dynamic and fueling demand for human-machine collaboration. Simultaneously, aging populations are opening up the market for elderly care service robots, making "robotics + elderly care" a viable solution.
According to forecasts from the Gaogong Robotics Industry Research Institute, the global humanoid robot market is expected to reach $20 billion by 2030, with a CAGR of 78% from 2026 to 2030, indicating substantial future market space.
More immediately, 2026 marks the transition of humanoid robots from labs to mass production globally, with overseas leaders and Chinese manufacturers converging in their production timelines. There is a consensus on prioritizing industrial applications first, with production capacity scaling from thousands to tens of thousands of units.
However, this broad potential has not translated into a sector-wide premium in the secondary market. From the start of 2026 to July 10, 2026, the humanoid robotics sector index fell 3.55%, underperforming the broader market indices, which rose.
In terms of valuation, as of July 10, 2026, the PE (TTM) for the humanoid robotics index was 31.67x, showing a clear downward trend over the past five years and remaining relatively stable in 2026. The overall sector valuation is not expensive.
Estun, however, is an exception. As of July 15, its total market capitalization was approximately HK$20.421 billion, with a static PE as high as 449x and a TTM PE around 143x. This valuation places it among the top tier of individual stocks over the past five years.
On one side is the sector's overall valuation near historical lows, and on the other is an individual stock's valuation at an absolute high. The market appears to have already priced into Estun all the potential themes: domestic substitution champion, humanoid robotics, and embodied AI.
Valuation Sustainability Concerns
So, with the H1 2026 earnings explosion, can Estun support its high valuation with its growth?
A closer look reveals structural flaws in this half-year performance surge. The core driver of the massive net profit increase was the fair value gain from the Nanjing Process asset restructuring—a one-time, non-recurring gain lacking sustainability. While non-GAAP net profit turned positive, its scale of only 60-75 million yuan indicates that the core business's profit base remains relatively small.
Although the company has achieved gross margin recovery through product mix optimization, supply chain cost reduction, and expense control—with the period expense ratio significantly declining year-on-year in 2025 and operational quality continuously improving—the profit foundation is still relatively weak and difficult to justify a valuation in the hundreds of times earnings.
Final Assessment
In the short term, the better-than-expected earnings forecast will likely fuel sentiment-driven trading, with sector imagination supporting a temporary valuation premium. However, in the long run, capital markets only pay for sustained, stable profits from core operations.
If subsequent non-GAAP net profit cannot maintain high growth, and the revenue contribution from the humanoid robotics business remains low over the long term, the current hundreds-of-times-earnings valuation lacks fundamental support, making a valuation correction an inevitable trend.
Only by achieving continuous product structure upgrades, scaling humanoid robotics business profitability, and ensuring steady growth in operating cash flow can Estun potentially achieve a Davis double-click of "earnings + valuation" growth.
Comments